Diagnostic Specialty Enzymes Market Trends

• Growing research in enzyme production and engineering is leading to the development of new enzymes with enhanced properties, such as improved specificity, stability, and catalytic efficiency, and higher yield of enzymes during production. Vendors are increasingly focusing towards surging the production efficiency of diagnostic specialty enzymes for enabling their commercial production.
  
• For instance, as part of the Smart Cell Project initiated by the New Energy and Industrial Technology Development Organization (NEDO), Asahi Kasei Pharma collaborated with the National Institute of Advanced Industrial Science and Technology (AIST) to enhance the production efficiency of cholesterol esterase, a specialty diagnostic enzyme.
  
• Vendors are increasingly focusing towards offering specialty enzymes as an individual product rather than as a part of kit. Availability of individual specialty enzymes has enabled the medical diagnostic settings to customize the assays and workflows as per the requirements.
  
• The COVID-19 pandemic has accelerated the adoption of point-of-care (POC) testing and rapid diagnostics technologies, to facilitate early diagnosis, and treatment of patients. POC testing has helped in providing rapid results within few minutes to hours, compared to traditional laboratory-based testing, thereby increasing the demand for diagnostic specialty enzymes globally.